Penumbra, Inc. (PEN) Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints
Go back to Penumbra, Inc. (PEN) Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints| (NYSE: PEN) | Delayed: 316.20 -1 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $317.20 | 52 Week High | $79.49 | |||
| Open | $316.27 | 52 Week Low | $40.23 | |||
| Day High | $316.91 | P/E | N/A | |||
| Day Low | $315.03 | EPS | $0.00 | |||
| Volume | 201,810 | |||||
